BRANDY FRANKLIN: Open Payments
NPI 1558084020 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$297 in 16 payments from 9 companies in 2025. Trend: 2023 $496 · 2024 $638 · 2025 $297
Food & beverage: $297
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $97 |
| Neurocrine BioSciences, Inc. | 3 | $45 |
| Almatica Pharma LLC | 2 | $40 |
| Collegium Pharmaceutical, Inc. | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Braeburn Inc. | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: VRAYLAR, INGREZZA, LOREEV XR, Jornay PM, REXULTI, CAPLYTA, BRIXADI, COBENFY.
Industry payments across KY — which companies pay providers there.
